Sec. 41 WpHG voting rights disclosure
Stratec Biomedical Systems AG
€29.90
16:30 03/12/24
The below Total Number of Voting Rights announcement is prepared on a settlement basis. Only purchased shares delivered to the company for cancellation have been deducted from the total voting rights.
Publication of new total number of voting rights according to Sec. 41 WpHG
Publication of total number of voting rights
1. Information on the issuer
BP p.l.c.
1 St. James's Square
London
SW1Y 4PD
UK
2. Type of capital measure
| Type of capital measure | Status at / date of effectiveness |
| Issue of subscription shares (Section 41 (2) WpHG) | |
X | Other capital measure (§ 41 (1) WpHG) | 28 October 2024 |
3. New total number of voting rights:
No. Ordinary shares of US$0.25 each (excluding treasury shares) | 16,117,947,603 |
No. Preference shares of £1 each | 12,706,252 |
No. Ordinary shares held in treasury | 716,799,020 |
New total number of voting rights (including treasury shares): | 16,839,829,123
|
Ordinary shares have one vote per share and preference shares two votes for every £5 in nominal capital held.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.